PTPRK and neoplasm: Intriguingly, our previous studies revealed that a receptor tyrosine phosphatase PTPRK removes the phosphorus groups from these tyrosine residues of CD133, attenuates CD133‐mediated xenograft tumor growth of colorectal cancer cells in nude mice and stimulates anti‐tumor drug‐induced cell death [18, 19].